Advertisement
Screener

CULLINAN THERAPEUTICS, INC. (CGEM) Increase (Decrease) in Other Operating Assets

CULLINAN THERAPEUTICS, INC. Increase (Decrease) in Other Operating Assets

CULLINAN THERAPEUTICS, INC. (CGEM) reported Increase (Decrease) in Other Operating Assets of $18.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-17.

Discontinued › Cash Flow

us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2022-03-17

  • CULLINAN THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2020-12-31 was $66.00K.
  • CULLINAN THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2020-09-30 was -$1.00K.
  • CULLINAN THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2020 was $18.00K.
Period endIncrease (Decrease) in Other Operating Assets 3 monthIncrease (Decrease) in Other Operating Assets 6 monthIncrease (Decrease) in Other Operating Assets 9 monthIncrease (Decrease) in Other Operating Assets 12 month
2020-12-31$66.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17
$65.00K
derived: sum of 2 quarters · filed 2022-03-17
$18.00K
10-K · filed 2022-03-17
2020-09-30-$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$48.00K
10-Q · filed 2021-11-09
2020-06-30-$47.00K
10-Q · filed 2021-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
Replimune Group, Inc. (REPL)United States$1.186B-3.13
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10